SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Dec 3, 2015
Insider Transaction Report
Form 4
Kovner Bruce
Director10% Owner
Transactions
- Sale
Common Stock
2015-12-01$0.43/sh−174,091$74,894→ 1,236,705 total(indirect: By Trust) - Sale
Common Stock
2015-12-02$0.43/sh−438,588$187,365→ 1,739,608 total(indirect: By LLC) - Sale
Common Stock
2015-12-03$0.41/sh−95,040$39,337→ 892,650 total(indirect: By Trust) - Sale
Common Stock
2015-12-01$0.43/sh−306,625$131,910→ 2,178,196 total(indirect: By LLC) - Sale
Common Stock
2015-12-03$0.41/sh−167,394$69,284→ 1,572,214 total(indirect: By LLC) - Sale
Common Stock
2015-12-02$0.43/sh−249,015$106,379→ 987,690 total(indirect: By Trust)
Holdings
- 4,000,000(indirect: By Trust)
Common Stock
- 2,279,146(indirect: By Spouse)
Common Stock
- 11,399,464(indirect: By LLC)
Common Stock
- 3,092,677
Common Stock
Footnotes (6)
- [F1]This constitutes the weighted average sale price. The prices range from $0.43 to $0.4378. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]This constitutes the weighted average sale price. The prices range from $0.42 to $0.4329. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This constitutes the weighted average sale price. The prices range from $0.41 to $0.428. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F5]These securities are owned by the wife of the Reporting Person and her estate planning vehicles.
- [F6]These shares are owned directly by KFO Holdings LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO Holdings LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.